|
Volumn 73, Issue 874, 2000, Pages 1031-1033
|
Are current tumour response criteria relevant for the 21st century?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
18 FLUOROMIDONIDAZOLE;
ANGIOGENESIS INHIBITOR;
ANGIOGENIN;
ANTINEOPLASTIC AGENT;
CANCER ANTIBODY;
CARBOCYCLIC THYMIDINE;
CYCLIN DEPENDENT KINASE;
EPIDERMAL GROWTH FACTOR RECEPTOR;
FIBROBLAST GROWTH FACTOR RECEPTOR;
IMIDAZOLE DERIVATIVE;
MATRIX METALLOPROTEINASE;
PROTEIN KINASE C;
UNCLASSIFIED DRUG;
VASCULOTROPIN RECEPTOR;
CANCER RESEARCH;
CANCER SIZE;
CANCER STAGING;
DIAGNOSTIC ERROR;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SCREENING;
DRUG TARGETING;
GENE THERAPY;
HEALTH CARE COST;
HUMAN;
METASTASIS;
NONHUMAN;
NOTE;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
POSITRON EMISSION TOMOGRAPHY;
PROGNOSIS;
RADIATION RESPONSE;
RADIOLOGIST;
TUMOR;
TUMOR VASCULARIZATION;
ARTICLE;
DISEASE COURSE;
NEOPLASM;
RADIOGRAPHY;
DISEASE PROGRESSION;
HUMANS;
NEOPLASMS;
|
EID: 0033709541
PISSN: 00071285
EISSN: None
Source Type: Journal
DOI: 10.1259/bjr.73.874.11271893 Document Type: Note |
Times cited : (39)
|
References (18)
|